A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy
In one study, mice treated with 20mg/kg of 5-amino-1mq three times daily for 11 days experienced a 5.1% reduction in body weight from baseline
Nature 632 , 131138 (2024)
They offer lozenges, tablets, pills, cheek gels, drops, and dissolving strips, promising to deliver the same active ingredients as the trademark medications without the injections
That doesn't automatically make compounded products unsafe but potency can vary, dosing errors are more likely, and source quality matters enormously